Review





Similar Products

cd123 antigen  (Miltenyi Biotec)
92
Miltenyi Biotec cd123 antigen
In vitro expression of dendritic cell (DC) gene markers in monocyte-derived DCs (moDCs) after stimulation with TRL-SFAs, TRL-MUFAs and TRL-PUFAs (TRL, triglyceride-rich lipoprotein) at 100 µg of TGs/mL for 6 days and in presence of GM-CSF and interleukin-4 (IL-4). DC maturation markers: ( a ) <t>CD123</t> and ( b ) CCR7. DC pro-inflammatory activation markers: ( c ) CD80 and ( d ) CD86. DC tolerogenic activation markers: ( e ) PD-L1 and ( f ) PD-L2. Control means non-treated cells in the presence of GM-CSF and IL-4. Values are presented as means ± SD ( n = 6) and those marked with different letters are significantly different ( p < 0.05).
Cd123 Antigen, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd123+antigen/CD123+CAR+Detection+Reagent%2C+human%2C+Biotin/pmc07656296-70-10-17
Average 92 stars, based on 1 article reviews
cd123 antigen - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier
monomeric recombinant human full length antigen  (R&D Systems)
93
R&D Systems monomeric recombinant human full length antigen
In vitro expression of dendritic cell (DC) gene markers in monocyte-derived DCs (moDCs) after stimulation with TRL-SFAs, TRL-MUFAs and TRL-PUFAs (TRL, triglyceride-rich lipoprotein) at 100 µg of TGs/mL for 6 days and in presence of GM-CSF and interleukin-4 (IL-4). DC maturation markers: ( a ) <t>CD123</t> and ( b ) CCR7. DC pro-inflammatory activation markers: ( c ) CD80 and ( d ) CD86. DC tolerogenic activation markers: ( e ) PD-L1 and ( f ) PD-L2. Control means non-treated cells in the presence of GM-CSF and IL-4. Values are presented as means ± SD ( n = 6) and those marked with different letters are significantly different ( p < 0.05).
Monomeric Recombinant Human Full Length Antigen, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd123+antigen/Recombinant+Human+IL-3R+alpha%2FCD123+Protein/pm39870691-212-3-10
Average 93 stars, based on 1 article reviews
monomeric recombinant human full length antigen - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
cd123-directed dual antigen re-targeting (dart) agent mgd 006  (MacroGenics inc)
90
MacroGenics inc cd123-directed dual antigen re-targeting (dart) agent mgd 006
In vitro expression of dendritic cell (DC) gene markers in monocyte-derived DCs (moDCs) after stimulation with TRL-SFAs, TRL-MUFAs and TRL-PUFAs (TRL, triglyceride-rich lipoprotein) at 100 µg of TGs/mL for 6 days and in presence of GM-CSF and interleukin-4 (IL-4). DC maturation markers: ( a ) <t>CD123</t> and ( b ) CCR7. DC pro-inflammatory activation markers: ( c ) CD80 and ( d ) CD86. DC tolerogenic activation markers: ( e ) PD-L1 and ( f ) PD-L2. Control means non-treated cells in the presence of GM-CSF and IL-4. Values are presented as means ± SD ( n = 6) and those marked with different letters are significantly different ( p < 0.05).
Cd123 Directed Dual Antigen Re Targeting (Dart) Agent Mgd 006, supplied by MacroGenics inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd123+antigen/mgah22+antibody/us11945863-74-8-7
Average 90 stars, based on 1 article reviews
cd123-directed dual antigen re-targeting (dart) agent mgd 006 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
allogeneic engineered t cells expressing an anti-cd123 chimeric antigen receptor  (Cellectis sa)
90
Cellectis sa allogeneic engineered t cells expressing an anti-cd123 chimeric antigen receptor
In vitro expression of dendritic cell (DC) gene markers in monocyte-derived DCs (moDCs) after stimulation with TRL-SFAs, TRL-MUFAs and TRL-PUFAs (TRL, triglyceride-rich lipoprotein) at 100 µg of TGs/mL for 6 days and in presence of GM-CSF and interleukin-4 (IL-4). DC maturation markers: ( a ) <t>CD123</t> and ( b ) CCR7. DC pro-inflammatory activation markers: ( c ) CD80 and ( d ) CD86. DC tolerogenic activation markers: ( e ) PD-L1 and ( f ) PD-L2. Control means non-treated cells in the presence of GM-CSF and IL-4. Values are presented as means ± SD ( n = 6) and those marked with different letters are significantly different ( p < 0.05).
Allogeneic Engineered T Cells Expressing An Anti Cd123 Chimeric Antigen Receptor, supplied by Cellectis sa, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd123+antigen/cd123+car+t/pmc09099711-138-14-0
Average 90 stars, based on 1 article reviews
allogeneic engineered t cells expressing an anti-cd123 chimeric antigen receptor - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
engineered t-cells expressing anti-cd123 chimeric antigen receptor  (Roboz Surgical)
90
Roboz Surgical engineered t-cells expressing anti-cd123 chimeric antigen receptor
In vitro expression of dendritic cell (DC) gene markers in monocyte-derived DCs (moDCs) after stimulation with TRL-SFAs, TRL-MUFAs and TRL-PUFAs (TRL, triglyceride-rich lipoprotein) at 100 µg of TGs/mL for 6 days and in presence of GM-CSF and interleukin-4 (IL-4). DC maturation markers: ( a ) <t>CD123</t> and ( b ) CCR7. DC pro-inflammatory activation markers: ( c ) CD80 and ( d ) CD86. DC tolerogenic activation markers: ( e ) PD-L1 and ( f ) PD-L2. Control means non-treated cells in the presence of GM-CSF and IL-4. Values are presented as means ± SD ( n = 6) and those marked with different letters are significantly different ( p < 0.05).
Engineered T Cells Expressing Anti Cd123 Chimeric Antigen Receptor, supplied by Roboz Surgical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd123+antigen/engineered+t+cells+expressing+anti+cd123+chimeric+antigen+receptor/pm35287669-425-33-0
Average 90 stars, based on 1 article reviews
engineered t-cells expressing anti-cd123 chimeric antigen receptor - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
chimeric antigen receptors (car) directed against the human cd123 antigen  (Cellectis sa)
90
Cellectis sa chimeric antigen receptors (car) directed against the human cd123 antigen
In vitro expression of dendritic cell (DC) gene markers in monocyte-derived DCs (moDCs) after stimulation with TRL-SFAs, TRL-MUFAs and TRL-PUFAs (TRL, triglyceride-rich lipoprotein) at 100 µg of TGs/mL for 6 days and in presence of GM-CSF and interleukin-4 (IL-4). DC maturation markers: ( a ) <t>CD123</t> and ( b ) CCR7. DC pro-inflammatory activation markers: ( c ) CD80 and ( d ) CD86. DC tolerogenic activation markers: ( e ) PD-L1 and ( f ) PD-L2. Control means non-treated cells in the presence of GM-CSF and IL-4. Values are presented as means ± SD ( n = 6) and those marked with different letters are significantly different ( p < 0.05).
Chimeric Antigen Receptors (Car) Directed Against The Human Cd123 Antigen, supplied by Cellectis sa, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd123+antigen/cd123+car+t/us10988542-837-31-19
Average 90 stars, based on 1 article reviews
chimeric antigen receptors (car) directed against the human cd123 antigen - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
anti-cd123 chimeric antigen receptor engineered t cells  (Novartis)
90
Novartis anti-cd123 chimeric antigen receptor engineered t cells
In vitro expression of dendritic cell (DC) gene markers in monocyte-derived DCs (moDCs) after stimulation with TRL-SFAs, TRL-MUFAs and TRL-PUFAs (TRL, triglyceride-rich lipoprotein) at 100 µg of TGs/mL for 6 days and in presence of GM-CSF and interleukin-4 (IL-4). DC maturation markers: ( a ) <t>CD123</t> and ( b ) CCR7. DC pro-inflammatory activation markers: ( c ) CD80 and ( d ) CD86. DC tolerogenic activation markers: ( e ) PD-L1 and ( f ) PD-L2. Control means non-treated cells in the presence of GM-CSF and IL-4. Values are presented as means ± SD ( n = 6) and those marked with different letters are significantly different ( p < 0.05).
Anti Cd123 Chimeric Antigen Receptor Engineered T Cells, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd123+antigen/anti+cd123+chimeric+antigen+receptor+engineered+t+cells/pmc07727315__NEJMra2026131_disclosures-156-8-38
Average 90 stars, based on 1 article reviews
anti-cd123 chimeric antigen receptor engineered t cells - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
cd123 antigen  (Becton Dickinson)
90
Becton Dickinson cd123 antigen
In vitro expression of dendritic cell (DC) gene markers in monocyte-derived DCs (moDCs) after stimulation with TRL-SFAs, TRL-MUFAs and TRL-PUFAs (TRL, triglyceride-rich lipoprotein) at 100 µg of TGs/mL for 6 days and in presence of GM-CSF and interleukin-4 (IL-4). DC maturation markers: ( a ) <t>CD123</t> and ( b ) CCR7. DC pro-inflammatory activation markers: ( c ) CD80 and ( d ) CD86. DC tolerogenic activation markers: ( e ) PD-L1 and ( f ) PD-L2. Control means non-treated cells in the presence of GM-CSF and IL-4. Values are presented as means ± SD ( n = 6) and those marked with different letters are significantly different ( p < 0.05).
Cd123 Antigen, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd123+antigen/anti+cd123/pm29524269-52-69-74
Average 90 stars, based on 1 article reviews
cd123 antigen - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
allogeneic engineered t-cells with talen system expressing anti-cd123 chimeric antigen receptor  (Cellectis sa)
90
Cellectis sa allogeneic engineered t-cells with talen system expressing anti-cd123 chimeric antigen receptor
Recruited clinical trials based on genome editing technologies (e.g. CRISPR/Cas, ZFN and TALEN).
Allogeneic Engineered T Cells With Talen System Expressing Anti Cd123 Chimeric Antigen Receptor, supplied by Cellectis sa, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd123+antigen/cd123+car+t/pmc06773888-58-5-2
Average 90 stars, based on 1 article reviews
allogeneic engineered t-cells with talen system expressing anti-cd123 chimeric antigen receptor - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


In vitro expression of dendritic cell (DC) gene markers in monocyte-derived DCs (moDCs) after stimulation with TRL-SFAs, TRL-MUFAs and TRL-PUFAs (TRL, triglyceride-rich lipoprotein) at 100 µg of TGs/mL for 6 days and in presence of GM-CSF and interleukin-4 (IL-4). DC maturation markers: ( a ) CD123 and ( b ) CCR7. DC pro-inflammatory activation markers: ( c ) CD80 and ( d ) CD86. DC tolerogenic activation markers: ( e ) PD-L1 and ( f ) PD-L2. Control means non-treated cells in the presence of GM-CSF and IL-4. Values are presented as means ± SD ( n = 6) and those marked with different letters are significantly different ( p < 0.05).

Journal: Nutrients

Article Title: Dietary Fatty Acids in Postprandial Triglyceride-Rich Lipoproteins Modulate Human Monocyte-Derived Dendritic Cell Maturation and Activation

doi: 10.3390/nu12103139

Figure Lengend Snippet: In vitro expression of dendritic cell (DC) gene markers in monocyte-derived DCs (moDCs) after stimulation with TRL-SFAs, TRL-MUFAs and TRL-PUFAs (TRL, triglyceride-rich lipoprotein) at 100 µg of TGs/mL for 6 days and in presence of GM-CSF and interleukin-4 (IL-4). DC maturation markers: ( a ) CD123 and ( b ) CCR7. DC pro-inflammatory activation markers: ( c ) CD80 and ( d ) CD86. DC tolerogenic activation markers: ( e ) PD-L1 and ( f ) PD-L2. Control means non-treated cells in the presence of GM-CSF and IL-4. Values are presented as means ± SD ( n = 6) and those marked with different letters are significantly different ( p < 0.05).

Article Snippet: Degree of differentiation of the resulting population was determined for CD123 antigen using anti-human CD123 monoclonal antibody (Miltenyi Biotec) by flow cytometry analysis (more than 95% of cells were positive for CD123) [ , , ].

Techniques: In Vitro, Expressing, Derivative Assay, Activation Assay, Control

Recruited clinical trials based on genome editing technologies (e.g. CRISPR/Cas, ZFN and TALEN).

Journal: Frontiers in Genetics

Article Title: Development and Clinical Translation of Approved Gene Therapy Products for Genetic Disorders

doi: 10.3389/fgene.2019.00868

Figure Lengend Snippet: Recruited clinical trials based on genome editing technologies (e.g. CRISPR/Cas, ZFN and TALEN).

Article Snippet: UCART123 , Cellectis S.A. , Allogeneic engineered T-cells with TALEN system expressing anti-CD123 chimeric antigen receptor , AML , NCT03190278.

Techniques: Clinical Proteomics, CRISPR, Plasmid Preparation, Mutagenesis, Knock-Out, Ex Vivo, Produced, Virus, Control, Expressing, Genetically Modified, Sequencing, Modification, Transfection